Country of Residence
United States
Age
16
Project title
Clinical Trailways
Project Summary: Describe your project in one sentence
Finding a life-saving clinical trial shouldn't require a Ph.D. or an insider network. Clinical Trailways (clinicaltrailways.org) is a student-built nonprofit platform that strips away ClinicalTrials.gov jargon and expired listings, turning everyday-language searches into local trial matches, treatment guidelines, and direct links to doctors and trials. It directs each cancer patient's step forward into informed care while helping researchers fill under-enrolled studies.
Website URL(s) or social media handles.
https://clinicaltrailways.org/; www.linkedin.com/in/ethanmonberg
Project Category
My project is a brand new / emerging idea
Project Stage
Pilot-Stage (We’ve tried an activity or two)
Founding Story: What was the spark that led you to start your project? What was the "Aha!" moment that led you to get started and see the potential for this to succeed?
My spark began with my family’s history with cancer, especially my Uncle John’s battle with mantle cell lymphoma. John held a Ph.D. and succeeded in a clinical trial before complications years later took his life. Despite his education and years of experience in research, even he didn’t know where to turn when diagnosed, later stating, "If one requires a Ph.D. and a well-connected network of insiders to find an appropriate clinical trial, something is terribly wrong with the system.” Seeing the lengths he and my family members went to in order to get him the appropriate care inspired me to try to find a solution. Things clicked when I spoke with patients and tested existing sites. As my grandfather Steven Johnson and Aunt Julie Monberg found when trying to find cancer care, community hospitals often lacked time or awareness of the latest trials. Meanwhile, registries like ClinicalTrials.gov were hard to navigate and listed completed trials as still open. Knowing I could program a clearer path, I built a patient-friendly prototype. My "aha!" moment came when I spoke with Merck patient-engagement expert Dr. Alycia Shilton-Lloyd and she emphasized that no app like this existed in the U.S., and that advocacy groups were actively looking for better solutions, which was confirmed when I attended a patient advocacy conference at Notre Dame. I knew I needed to pursue this solution.
The Problem: What problem are you helping to solve? Why does it matter to you and your community?
What my family experienced reflects a massive, two-sided problem. In 2026, an estimated 2,041,910 U.S. cancer cases will be diagnosed and 618,120 people will die, yet only an estimated 144,976 will join a treatment trial. Rare-disease patients also face issues obtaining access to doctors and trials. Most cancer patients rely on community hospitals (where most go for treatment) or sites like ClinicalTrials.gov. Yet community hospitals and some doctors often lack time for key decisions, give conflicting advice, or don't know of the latest trials. Existing websites are hard to navigate, return unrelated results if small details are missing, and can list trials past their completion date as open. Moreover, patients often don't look for trials until they've started treatment, which likely excludes them. Meanwhile, in Philadelphia alone, over 2,500 trials enrolled patients in 2025, including 1,368 at Penn Medicine, 600 at Jefferson, 316 pediatric oncology trials at the Children’s Hospital of Philadelphia, and 313 at Fox Chase Cancer Center, yet many could not find enough patients. This matters deeply to my community (as well as the world) because most of us probably know and love someone who will face cancer, and trials offer access to world-class oncologists and often free treatment. Patients shouldn't miss the cutting-edge, life-saving care that exists in their own communities.
Your Solution: How are you solving this problem? Share your specific solution.
I built Clinical Trailways (clinicaltrailways.org), a nonprofit web platform developed through Springside Chestnut Hill Academy's Venture Accelerator class, that turns confusing clinical trial registries into an approachable starting point for patients and families. Rather than forcing users through dense medical jargon, the platform lets them search cancer trials in their own words and automatically extracts key search terms. Using the ClinicalTrials.gov’s publicly-available Application Programming Interface, Clinical Trailways pulls study listings and lets patients filter by location, recruitment status, and trial phase (and soon cancer subtype and genetic biomarker), while automatically filtering out studies past their completion date. The site features a layperson-friendly design with dedicated tabs for Trials, Guidelines, Advocacy, and App Info. The App Info hub explains in everyday language what clinical trials are, why evidence-based patient guidelines matter, and how patient advocacy groups support families. I am now expanding the platform to include a button that directly calls or emails the study registrar, eliminating a common hurdle for patients. Operating as an ultra-lean nonprofit earns trust from patients, nurses, and advocacy groups. In this way, Clinical Trailways empowers patients while helping researchers find trial candidates.
Impact: How has your project created impact / made a difference so far? Or, if at an early stage, what will impact look like?
At this early stage, Clinical Trailways’ impact centers on launching a live minimum viable product at clinicaltrailways.org and validating it with patients, clinicians, and patient advocacy organizations. Merck patient-engagement expert Dr. Alycia Shilton-Lloyd reviewed the concept and emphasized that no app like this exists in the U.S. and that patient advocacy groups are looking for trusted sources of information. At the University of Notre Dame, Pre-Med head Rev. James Foster, CSC, MD, invited me to attend Rare Disease Grand Rounds focused on patient access. Following that, I attended the October 9, 2026 Brumm Patient Advocacy Summit and discussed the app with organizers Joshua Brumm (CEO, Crescent Biopharma) and Professor Barbara Calhoun (Notre Dame Patient Advocacy Director), who both stressed the immediate need for the app and looked forward to utilizing it once completed. I hope that Clinical Trailways will have a positive impact on cancer patients and their families across the United States. The hope is that they will be able to turn to Clinical Trailways to connect to world-class doctors, cutting-edge care, treatment guidelines, the latest clinical trials and research, as well as patient advocacy organizations and "wrap-around care" (financial, legal, transportation, and home-care services). The info is all out there; it just needs to be gathered and easily accessible.
Your Innovation: What is different about your project compared to other programs or solutions already out there? How is your project new or innovative?
Most existing tools like ClinicalTrials.gov are built as technical databases rather than sources of information for patients or their families. For example, ClinicalTrials.gov uses the medical terminology that may be needed to obtain approval from the FDA, but which is completely confusing to the average person. Additionally, even a simple search will turn up unrelated results and trials that have closed but are still marked as open. Clinical Trailways innovates across four areas: Natural-Language Search & Fresh Data: Patients search in their own words while the platform extracts key terms and filters out trials past their completion date. Unified Platform: Rather than separating trial search from broader care, Clinical Trailways combines Trial Matching, Standard of Care/Guidelines, Patient Advocacy recommendations, and direct contacts with doctors via an easy-to-understand interface. Dual-Sided Value: The platform empowers patients to take control of their own care by allowing them to contact trials and doctors directly, while helping clinical trial doctors find candidates for their research. Platform Built Upon Trust: Every aspect of the platform is created to build trust with users. The organization operates as a lean nonprofit and uses open-source code, so there is no commercial agenda. Patients remain anonymous, and use the site as a search tool, which avoids issues with HIPAA and storing sensitive information. Finally, the guidance comes directly from the source: the clinical trial listings themselves (in addition to the official National Comprehensive Cancer Network treatment guidelines, which I hope to obtain licensing to in the near future).
How many people are on your team?
1
Your team: What role(s) do your team members play? How do you share leadership with them?
I am the sole founder and developer. However, I have built Clinical Trailways with guidance from my teachers in my Venture Accelerator class: Edward Glassman, Scott Kirker, and Julie Knutson (to whom I will always be grateful). I have sought feedback from Dr. Alycia Shilton-Lloyd at Merck, Barbara Calhoun and Rev. James Foster at Notre Dame, and Joshua Brumm at Crescent Biopharma. Next, I am recruiting a medical advisor for content review and partnering with advocacy groups.
What’s Next: What are the next steps you plan to take to grow or strengthen your project over the next year? If your project is still in the idea stage, describe the steps you will take over the next three months to launch or begin developing it.
Over the next three to twelve months, my roadmap focuses on accuracy, usability, and partnerships: >Clinical Accuracy & Safeguards: Conduct a 25-result data accuracy audit against the source registry, publish disclaimers and a privacy policy on the live site, build out a patient resources hub, add step-by-step eligibility and doctor-finding questions, and recruit a medical/clinical advisor to review site content. >UX Expansion: Complete documented usability tests with target users and deploy direct doctor-contact templates. >NCCN Guidelines Integration: Meet with NCCN leadership and Business Development in nearby Plymouth Meeting, PA, to seek written permission for their guidelines. If permission is not granted, use the publicly-available Application Programming Interface data from Memorial Sloan Kettering for the guidelines and eligibility content questions. >Advocacy Partnerships: Execute outreach across national nonprofits, such as the Leukemia and Lymphoma Society and Blood Cancer United, to form referral partnerships. Attend national cancer conferences, such as ASCO and ASH. Longer term, I plan to add transportation, financial, and legal resources.
How do you encourage other people to join your project or learn about the problem you’re working on? If you have a new idea, tell us how you will do this in the future.
I engage others by combining personal storytelling with structured outreach. First, through Narrative 4, I created a campaign video, sharing my Uncle John's story and the gap in enrollment in clinical trials for cancer. The campaign invites supporters to join the mission and fund development, domain setup, and attendance at ASCO and ASH oncology meetings. Second, I participate directly in patient-advocacy spaces. Merck patient-engagement expert Alycia Shilton-Lloyd reviewed my concept and offered to connect me with advocacy groups. Notre Dame Pre-Med head Rev. James Foster suggested I attend Rare Disease Grand Rounds and contact Patient Advocacy Director Barbara Calhoun, who then invited me to the October 2026 Brumm Patient Advocacy Summit. There, Calhoun and Crescent Biopharma CEO Joshua Brumm stressed the immediate need for the app and looked forward to utilizing it in their work once completed. I engage in direct, in-person one-on-one networking with experts in the healthcare field, in order to gain feedback and advice on the app as well as develop partnerships. This paves the way for formal partnerships featuring advocacy groups on the site so they can promote it and share new trials directly. Finally, the site itself educates and encourages others to join. The App Info Hub educates visitors in plain language on trials, guidelines, and advocacy groups.
